This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML medical supplies. The contract, valued at $18,259.84, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical. It has an ultimate completion date of December 31, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $9,431.75 and runs through December 6, 2024. It is a firm fixed-price contract for the supply of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty medication. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML syringes, with a ceiling value of $9,681.62 and a completion date of August 21, 2024. The award is for a firm fixed-price delivery order, and the contract type is not set aside. Amerisourcebergen is the prime contractor, and the delivery order is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of ACTEMRA 162 MG/0.9 ML syringes. The contract is a Delivery Order with a Firm Fixed Price type and has a ceiling value of $7,442.12. The contract does not have a set-aside designation, and the ultimate completion date is September 5, 2024.
Amerisourcebergen is the prime contractor for this award, which is part of a larger Indefinite...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,799.91, is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product. This order was issued under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, valued at up to $999,999,999.00, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The $16,330.56 firm fixed-price delivery order has an ultimate completion date of December 2, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $1,973.16, is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to support military treatment programs and facilities. The contract has an ultimate completion date of April 10, 2024.
Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,085.48 firm fixed price delivery order is for the supply of ACTEMRA 162 MG/0.9 ML syringes, a specialty medication used to treat certain medical conditions. The contract has a completion date of July 26, 2024 and is not set aside for any small business categories. AmerisourceBergen holds a significant Indefinite Delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract, valued at $10,335.30, is for the delivery of ACTEMRA 162 MG/0.9 ML syringes to support military treatment programs and medical facilities. The delivery order has an ultimate completion date of March 27, 2024.
Amerisourcebergen Drug Corp holds an...
This federal contract award, valued at $16,473.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a pharmaceutical product, with a completion date of April 22, 2024.
The contract is a delivery order, with a firm fixed price pricing type. It is not associated with a set-aside program....